{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:01:27Z","timestamp":1784804487759,"version":"3.55.0"},"reference-count":47,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: A thorough comprehension of the essential molecules and related processes underlying the carcinogenesis, proliferation, and recurrence of acute myeloid leukemia (AML) is crucial. This study aimed to investigate the expression levels, diagnostic and prognostic significance and biological roles of Bcl-2-associated athanogene 4 (BAG4) in AML carcinogenesis. Materials and Methods: Gene expression profiles were analyzed using publicly available datasets, particularly GSE9476 and TCGA, using tools such as GEO2R, GEPIA2, UALCAN and TIMER2.0. The immune infiltration correlation was examined using the GSCA platform, while the function of BAG4 at the single-cell level was analyzed via CancerSEA. Protein\u2013protein and gene\u2013gene interaction networks were constructed using STRING and GeneMANIA, and enrichment analyses were performed using GO, KEGG and DAVID. Expression validation was performed using RT-qPCR in HL-60 (AML) and HaCaT (normal) cells, and ROC curve analysis evaluated the diagnostic accuracy. Results: BAG4 was significantly overexpressed in AML tissues and cell lines compared with healthy controls. High BAG4 expression was associated with poor overall survival and strong diagnostic power (AUC = 0.944). BAG4 was positively associated with immune cell infiltration and negatively associated with CD4+\/CD8+ T and NK cells. At the single-cell level, BAG4 was associated with proliferation, invasion, and DNA repair functions. Functional network analysis showed that BAG4 interacted with apoptosis and necroptosis-related genes such as BCL2, BAG3 and TNFRSF1A and was enriched in pathways such as NF-\u03baB, TNF signaling and apoptosis. Conclusions: BAG4 is overexpressed in AML and is associated with adverse clinical outcomes and immune modulation. It may play an important role in leukemogenesis by affecting apoptotic resistance and immune evasion. BAG4 has potential as a diagnostic biomarker and treatment target in AML, but further in vivo and clinical validation is needed.<\/jats:p>","DOI":"10.3390\/medicina61081333","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T07:54:26Z","timestamp":1753343666000},"page":"1333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expression Analysis, Diagnostic Significance and Biological Functions of BAG4 in Acute Myeloid Leukemia"],"prefix":"10.3390","volume":"61","author":[{"given":"Osman","family":"Akidan","sequence":"first","affiliation":[{"name":"Department of Hematology, Mengucek Gazi Education and Research Hospital, 24180 Erzincan, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"Yaman","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Trabzon Kanuni Training and Research Hospital, 61290 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Ozer Yaman","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Trabzon Kanuni Health Practice and Research Hospital, Trabzon University of Health Sciences, 61290 Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-3295","authenticated-orcid":false,"given":"Sema","family":"Misir","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, 58140 Siva, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fu, D., Zhang, B., Wu, S., Zhang, Y., Xie, J., Ning, W., and Jiang, H. (2021). Prognosis and characterization of immune microenvironment in acute myeloid leukemia through identification of an autophagy-related signature. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.695865"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"El Omri, H., Taha, R.Y., Elomri, A., Kacem, N., Elsabah, H., Ellahie, A.Y., Gamil, A., Ibrahim, F., Soliman, D.S.A., and Akiki, S.J.L.E. (2020). Acute myeloid leukemia in qatar (2010\u20132016): Clinical, biological, and prognostic factors and treatment outcomes. Front. Genet., 11.","DOI":"10.3389\/fgene.2020.00553"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Santoro, N., Salutari, P., Di Ianni, M., and Marra, A. (2024). Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202403.0836.v1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2016.121","article-title":"The PI3K\/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia","volume":"38","author":"Deng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lin, M.S., Zhong, H.Y., Yim, R.L.H., Chen, Q.Y., Du, H.L., He, H.Q., Lin, K., Zhao, P., Gao, R., and Gao, F. (2022). Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-10155-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1007\/s00277-024-05841-6","article-title":"Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia","volume":"103","author":"Abulimiti","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s12094-023-03108-6","article-title":"Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development","volume":"25","author":"Wang","year":"2023","journal-title":"Clin. Transl. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1007\/s11033-023-08721-w","article-title":"Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia","volume":"50","author":"Guo","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41408-024-01143-2","article-title":"Current status and research directions in acute myeloid leukemia","volume":"14","author":"Kantarjian","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.canlet.2021.08.020","article-title":"Bcl2-associated athanogene 4 promotes the invasion and metastasis of gastric cancer cells by activating the PI3K\/AKT\/NF-\u03baB\/ZEB1 axis","volume":"520","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"107498","DOI":"10.1016\/j.pharmthera.2020.107498","article-title":"A BAG\u2019s life: Every connection matters in cancer","volume":"209","author":"Mariotto","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bao, F., An, S., Yang, Y., and Xu, T.R. (2023). SODD promotes lung cancer tumorigenesis by activating the PDK1\/AKT and RAF\/MEK\/ERK signaling. Genes, 14.","DOI":"10.3390\/genes14040829"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1006\/bbrc.2000.2610","article-title":"Enhanced expression of Silencer of death domains (SODD\/BAG-4) in pancreatic cancer","volume":"271","author":"Ozawa","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1158\/1078-0432.CCR-07-0327","article-title":"BAG-4\/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer","volume":"13","author":"Annunziata","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.humpath.2016.02.023","article-title":"BAG-1\/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma","volume":"54","author":"Davidson","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Cisterne, A., Baraz, R., Khan, N.I., Welschinger, R., Basnett, J., Fung, C., Rizos, H., Bradstock, K.F., and Bendall, L.J. (2014). Silencer of death domains controls cell death through tumour necrosis factor-receptor 1 and caspase-10 in acute lymphoblastic leukemia. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0103383"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/gutjnl-2016-312794","article-title":"Protein and glycomic plasma markers for early detection of adenoma and colon cancer","volume":"67","author":"Rho","year":"2018","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2020-141399","article-title":"Targeting Mcl-1 enhances the activity of tyrosine kinase inhibitor gilteritinib in FLT3 mutated AML","volume":"136","author":"Carter","year":"2020","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/CM9.0000000000003254","article-title":"Bioinformatics tools and resources for cancer and application","volume":"137","author":"Huang","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.csbj.2024.02.018","article-title":"Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: A review","volume":"23","author":"Rosati","year":"2024","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.20500","article-title":"Identification of genes with abnormal expression changes in acute myeloid leukemia","volume":"47","author":"Stirewalt","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_22","first-page":"776","article-title":"Differential expression and functional analysis of lung cancer gene expression datasets: A systems biology perspective","volume":"18","author":"Bao","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A Web Server for Gene Set Cancer Analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Liu, C.J., Hu, F.F., Xie, G.Y., Miao, Y.R., Li, X.W., Zeng, Y., and Guo, A.Y. (2023). GSCA: An Integrated Platform for Gene Set Cancer Analysis at Genomic, Pharmacogenomic, and Immunogenomic Levels. Brief. Bioinform., 24.","DOI":"10.1093\/bib\/bbac558"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"D900","DOI":"10.1093\/nar\/gky939","article-title":"CancerSEA: A cancer single-cell state atlas","volume":"47","author":"Yuan","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkq973","article-title":"The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored","volume":"39","author":"Szklarczyk","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The Gene MANIA prediction server: Biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Donaldson","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkm415","article-title":"DAVID Bioinformatics Resources: Expanded annotation database and novel algorithms to better extract biology from large gene lists","volume":"35","author":"Huang","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12935-024-03368-4","article-title":"Comprehensive insights into AML relapse: Genetic mutations, clonal evolution, and clinical outcomes","volume":"24","author":"Kim","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41571-021-00509-w","article-title":"Towards precision medicine for AML","volume":"18","author":"Wei","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/16078454.2022.2061107","article-title":"Bioinformatics analysis of the expression and clinical significance of the NUP210 Gene in acute myeloid leukaemia","volume":"27","author":"Li","year":"2022","journal-title":"Hematology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1007\/s00432-023-04871-3","article-title":"Analysis of prognostic biomarker models and immune microenvironment in acute myeloid leukemia by integrative bioinformatics","volume":"149","author":"Wang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(02)00456-1","article-title":"What\u2019s in the \u2018BAG\u2019?\u2014A functional domain analysis of the BAG-family proteins","volume":"188","author":"Doong","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11596-007-0328-2","article-title":"Expression of SODD and P65 in ALL of children and its relationship with chemotherapeutic drugs","volume":"27","author":"Tao","year":"2007","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_41","first-page":"9542311","article-title":"KIF22 in the Prognosis and Immune Biomarking of Pan-Cancer","volume":"1","author":"Guo","year":"2023","journal-title":"J. Immunol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s12672-024-01697-4","article-title":"Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types","volume":"15","author":"Xu","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s10549-011-1520-4","article-title":"Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer","volume":"29","author":"Madeleine","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.7150\/thno.82431","article-title":"Targeting HSF1 for cancer treatment: Mechanisms and inhibitor development","volume":"13","author":"Chin","year":"2023","journal-title":"Theranostics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/1568009618666181018162117","article-title":"HSF1 as a cancer biomarker and therapeutic target","volume":"19","author":"Carpenter","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: Attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:58Z","timestamp":1760033698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/8\/1333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["medicina61081333"],"URL":"https:\/\/doi.org\/10.3390\/medicina61081333","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]}}}